Citadel's $666B Q4 2025 Rebalance: Cutting Index Hedges, Adding Alphabet and Semis

Marcus Chen

Citadel Advisors ended Q4 2025 with a $665.9B 13F portfolio, up 1.33% QoQ, while reducing top-position concentration. The filing shows a clear rebalance: heavier Alphabet and semiconductor exposure, paired with lower SPY/QQQ index hedge weight.

Citadel Advisors' Q4 2025 13F shows a portfolio that got larger but less top-heavy. Total reported value rose to $665.9B (+1.33% QoQ), while top-position concentration declined across Top 1, Top 2, Top 5, and Top 10 buckets. The key move was not an all-in risk-on bet, but a deliberate rebalance: adding to selected AI and semiconductor names while trimming broad index hedge exposure.

TL;DR

  • Q4 2025 13F value rose from $657.1B to $665.9B (+1.33% QoQ).
  • Concentration fell: Top 1 weight dropped from 7.08% to 5.93%; Top 10 fell from 34.73% to 33.00%.
  • Largest issuer-level net adds: Alphabet (+$6.63B), Micron (+$3.22B), Amazon (+$3.13B), Broadcom (+$2.50B).
  • Largest issuer-level net cuts: SPY (-$7.03B), QQQ (-$6.97B), MicroStrategy (-$5.66B).

Q4 Filing Snapshot: Bigger Book, Similar Breadth

Citadel Advisors filed Q4 2025 holdings on 2026-02-17 (report date 2025-12-31). Portfolio value increased by $8.72B QoQ, and consolidated unique holdings rose from 6,446 to 6,510 (+0.99%).

Citadel 13F Portfolio Value: Q3 vs Q4 2025

Loading Chart...

That combination matters: the portfolio grew, but not through a narrow concentration spike. Instead, the book expanded while redistributing weight away from the very top positions.

Concentration De-Risking: Top Weights Came Down

Concentration Shift: Top Weights Fell Across the Board

Loading Chart...

Every major concentration bucket moved lower in Q4. Top 1 weight fell -1.15pp (7.08% to 5.93%), and Top 2 fell -2.28pp (13.66% to 11.38%). This is consistent with a manager reducing single-point portfolio dependency while still maintaining very large gross exposure.

Where Gross Exposure Still Sits

Q4 2025 Top Positions by Portfolio Weight

Loading Chart...

Even after the concentration step-down, the largest Q4 exposures remained in index and mega-cap complex names: SPY, QQQ, TSLA, NVDA, AAPL, and META. Notably, all top-10 consolidated lines show optionType=Put in the current filing view, reinforcing that 13F top-line value is about reported long positions, not full net exposure.

Rebalance Ledger: Add to AI Complex, Trim Broad Index Hedges

Largest Issuer-Level Rebalances (Q4 Value - Q3 Value, USD Billions)

Loading Chart...

At issuer level, Q4's biggest net add was Alphabet (+$6.63B combined across share classes), followed by Micron, Amazon, Tesla, and Broadcom. On the trim side, Citadel reduced SPY and QQQ by roughly $14.0B combined, alongside cuts in MSTR, COIN, and MSFT.

Did Citadel cut index exposure in Q4 2025?

Yes, in aggregate. SPY fell by $7.03B and QQQ by $6.97B, with additional reduction in IWM (-$1.40B). At the same time, the filing shows selective additions in other macro sleeves such as TLT (+$1.11B), HYG (+$1.08B), SLV (+$2.29B), and DIA (+$2.28B).

What did Citadel buy in Q4 2025?

Among notable new lines, ISRG appeared as a fresh position (~$1.16B), and TGT as another new allocation (~$1.09B). Overall turnover stayed very high: 1,372 new positions, 1,308 sold, and 7,809 total changed lines between the two latest filings.

Analyst Take

Q4 reads as a multi-strategy rebalance, not a one-direction macro bet: less concentration at the top, smaller broad-index hedge stack, and larger issuer-specific exposure in AI and semiconductor-linked names. For readers tracking filing-season cross-manager context, compare this setup with Whale Fund Filings Decoded and the Q4 Institutional Consensus Report.

Methodology

  • Primary data source: /api/v1/filers/0001423053/holdings for 2025Q3 and 2025Q4 in consolidated view (full pagination).
  • Issuer-level net rebalance computed as Q4 value minus Q3 value after aggregating consolidated rows by normalized issuer_name.
  • Trade-intent cross-check from /api/v1/filers/0001423053/changes (new/sold/increased/decreased and share deltas).
  • 13F caveat: reported long positions and option line items do not represent full net portfolio risk.
Explore all research